Search

The permanent anti-mold protection of textile surfaces, particularly those utilized in the manufacture of outdoor sporting goods, is still an issue that requires cutting-edge solutions. This study attempts to obtain antifungal nanocoatings on four selected fabrics used in the production of high-mountain clothing and sleeping bags, and on PET foil as a model substrate, employing the cold plasma technique for this purpose. Three plasma treatment procedures were used to obtain such nanocoatings: plasma-activated graft copolymerization of a biocidal precursor, deposition of a thin-film matrix by plasma-activated graft copolymerization and anchoring biocidal molecules therein, and plasma polymerization of a biocidal precursor. The precursors used represented three important groups of antifungal agents: phenols, amines, and anchored compounds. SEM microscopy and FTIR-ATR spectrometry were used to characterize the produced nanocoatings. For testing antifungal properties, four species of common mold fungi were selected: A. niger , A. fumigatus , A. tenuissima , and P. chrysogenum . It was found that the relatively best nanocoating, both in terms of plasma process performance, durability, and anti-mold activity, is plasma polymerized 2-allylphenol. The obtained results confirm our belief that cold plasma technology is a great tool for modifying the surface of textiles to provide them with antifungal properties.

We treated Candida albicans cells with a sublethal dose of nonequilibrium (cold) atmospheric-pressure He plasma and studied alterations in the genome of this fungus as well as changes in the phenotypic traits, such as assimilation of carbon from carbohydrates, hydrolytic enzyme activity, and drug susceptibility. There is a general problem if we use cold plasma to kill microorganism cells and some of them survive the process-whether the genotypic and phenotypic features of the cells are significantly altered in this case, and, if so, whether these changes are environmentally hazardous. Our molecular genetic studies have identified six single nucleotide variants, six insertions, and five deletions, which are most likely significant changes after plasma treatment. It was also found that out of 19 tested hydrolytic enzymes, 10 revealed activity, of which nine temporarily decreased their activity and one (naphthol-AS-BI- phosphohydrolase) permanently increased activity as a result of the plasma treatment. In turn, carbon assimilation and drug susceptibility were not affected by plasma. Based on the performed studies, it can be concluded that the observed changes in C. albicans cells that survived the plasma action are not of significant importance to the environment, especially for the drug resistance and pathogenicity of this fungus.

Introduction: Cough is one of the most frequent symptoms reported to pulmonologists. The role of bronchoscopy in the diagnostic work-up of chronic cough is not clearly defined. The aim of this study was to evaluate the utility of fiberoptic bronchoscopy (FOB) and additional testing of samples collected during FOB in the differential diagnosis of chronic cough in adults., Material and Methods: This was a single-center retrospective study. Out of 7115 conventional white light FOB examinations, we finally selected 198 with cough as the only indication., Results: In 40.9% of bronchoscopic examinations, no visible cause of cough was found. Visual signs of chronic bronchitis (CB) were detected in 57.6% of reports. Only in 3 cases (1.5%) bronchoscopy revealed a potential cause of chronic cough other than CB. Mycobacterium tuberculosis or other mycobacteria were spotted in none of the samples. In 91.1% of bronchoalveolar lavage (BAL) cytologic examinations, at least one cell count abnormality was detected, but only in case of increased percentage of eosinophils, it might be considered clinically relevant. In 53% of bacteriological culture results, at least one potentially pathogenic bacterium was isolated., Conclusions: The present study results strengthen the evidence that FOB combined with additional testing of airway specimens obtained during FOB is not a powerful tool in the differential diagnosis of chronic cough, and FOB as a diagnostic tool may be overused. The appropriate timing and decision regarding referral for FOB and additional testing of achieved material requires careful clinical consideration.